FILTER
FILTERED INTERVIEW RESULTS
Ana Karla Garza & Paul Capone
AKG: President, Looper & PC: Sales, Kosmos Logistics
Kosmos logistics is growing with Mexico’s rapidly developing manufacturing sector, particularly servicing the automotive industry.
Fernando Gutiérrez
PRESIDENT, MEXICAN COLLEGE OF CIVIL ENGINEERS (CICM)
Mexico is upgrading its infrastructure, offering opportunities for steel producers and construction firms alike.
J. Rogelio Garza Garza
UNDERSECRETARY OF INDUSTRY AND COMMERCE, MINISTRY OF ECONOMY
The Undersecretary of Industry and Commerce explains its policies towards driving growth for Mexico’s steel industry.
Mauricio Morales
GENERAL MANAGER, GALVAPRIME
Galvaprime explains the market for supplying metals to Mexico’s manufacturing sector.
Stefano Maggiolino
PRESIDENT AND CEO, TENOVA HYL
Tenova HYL holds approximately 50% of the direct induced iron (DRI) reduction market, a technology which it has pioneered.
Gerardo Treviño, Carlos Lopez & Roberto Benevides
PARTNERS, DELOITTE
"The market in Mexico used to be only based on price, but now clients are also looking for quality and are able to pay a little more. Companies must have high efficiency and be prepared to produce products when the client needs them.”
Mario Tijerina
CFO, ROCA ACERO
Roca Acero speaks to GBR about the current state of the scrap market in northern and central Mexico where the ‘Trump effect’ and the automotive sector are driving the market.
Demófilo Maldonado Cortés
RESEARCH PROFESSOR, UNIVERSITY OF MONTERREY (UDEM)
University of Monterrey explains to GBR how it prepares its students for industry.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
